Inactive Instrument

Highlights Myovant Sciences Ltd.

Equities

MYOV

BMG637AM1024

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Sumitomo Pharma Unit Closes $1.7 Billion Purchase of Myovant Sciences	23-03-14	MT
Sumitovant Biopharma Ltd. completed the acquisition of remaining 47.83% stake in Myovant Sciences Ltd..	23-03-09	CI
Myovant Sciences Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-01-26	CI
Earnings Flash (MYOV) MYOVANT SCIENCES Reports Q3 Revenue $100.2M	23-01-26	MT
Myovant Sciences Fiscal Q2 Loss Widens, Revenue Rises	22-10-26	MT
Myovant Sciences Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-10-26	CI
Earnings Flash (MYOV) MYOVANT SCIENCES Reports Q2 Revenue $104.8M	22-10-26	MT
Sumitomo Pharma Unit to Acquire Remaining 48% of Myovant Sciences for $1.7 Billion	22-10-25	MT
Myovant Sciences Share Rise After Agreement to be Fully Acquired by Sumitovant Biopharma	22-10-24	MT
Japan's Sumitomo Pharma to buy rest of Myovant in sweetened deal	22-10-24	RE
Myovant Sciences to be Fully Acquired by Sumitovant Biopharma	22-10-24	MT
Sumitovant Biopharma to buy Myovant for $27 per share	22-10-23	RE
Sumitovant Biopharma Ltd. signed an agreement to acquire a 47.83% stake in Myovant Sciences Ltd for $1.2 billion.	22-10-22	CI
Myovant Sciences Rejects Go-Private Offer From Sumitovant Biopharma, Citing Valuation Concerns	22-10-03	MT
Top Premarket Gainers	22-10-03	MT
Myovant Sciences Rejects Preliminary Full Acquisition Offer by Sumitovant Biopharma	22-10-03	MT
Myovant Sciences rejects $2.5 bln takeover bid from Sumitovant, Sumitomo Pharma	22-10-02	RE
Sumitovant Biopharma, Sumitomo Pharma submit offer to buy Myovant Sciences in $2.5 billion deal	22-10-02	RE
Sumitovant Biopharma Ltd. cancelled the acquisition of remaining 47.83% stake in Myovant Sciences Ltd. for $1.2 billion.	22-10-01	CI
Sumitovant Biopharma Ltd. entered into a non-binding proposal to acquire Myovant Sciences Ltd. for $1.2 billion.	22-10-01	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Myovant Sciences Ltd.

Equities

MYOV

BMG637AM1024

Highlights

Filters